Skip to main content
FOCIS 2023 Main banner
Final Program


Scientific Program

  1. Home

  • Thursday, Jun 22nd
    1:25 PM – 1:40 PM  
    Crispr-mediated Deletion of PD1 to Enhance the Efficacy of Human CAR Tregs
    Location: Salon F-G
    Presenting Author: Dominic A. Boardman, Ph.D. – The University of British Columbia
    Engineered Cell Therapy - Non-Oncology
  • Thursday, Jun 22nd
    2:05 PM – 2:20 PM  
    GNTI-122 Is a Stable Engineered Regulatory T Cell Therapy for Type 1 Diabetes That Is Specific, Expandable, and Efficacious in in Vivo Models
    Location: Salon F-G
    Presenting Author: Ashley Landuyt, Ph.D. – GentiBio, Inc
    Engineered Cell Therapy - Non-Oncology